Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;102:2535-2540

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, X.
Right arrow Articles by Kem, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, X.
Right arrow Articles by Kem, D. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Arrythmias-basic studies
Right arrow Cell signalling/signal transduction
Right arrow Acute myocardial infarction

(Circulation. 2000;102:2535.)
© 2000 American Heart Association, Inc.


Basic Science Reports

Ischemic Inactivation of G Protein–Coupled Receptor Kinase and Altered Desensitization of Canine Cardiac ß-Adrenergic Receptors

Presented in part at the 72nd Scientific Sessions of the American Heart Association, Atlanta, Ga, November 7–10, 1999, and published in abstract form (Circulation. 1999;100[suppl I]:I-274).

Xichun Yu, MD; Min Zhang, MD; Kimberly Kyker, MS; Eugene Patterson, PhD; Jeffrey L. Benovic, PhD; David C. Kem, MD

From the Departments of Medicine (X.Y., M.Z., K.K., E.P., D.K.) and Cell Biology (E.P.) and the Cardiac Arrhythmia Research Institute (E.P., D.C.K.), University of Oklahoma Health Sciences Center and VA Medical Center, Oklahoma City; and the Department of Microbiology and Immunology, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pa (J.L.B.).

Correspondence to David C. Kem, MD, Endocrinology, Metabolism, and Hypertension, 3E107, 913 N E 13th, Oklahoma City, OK 73104. E-mail david-kem{at}ouhsc.edu

Background—G protein–coupled receptor kinases (GRKs) modulate myocardial ß-adrenergic receptor (ßAR) signaling. We examined whether GRK activity was altered 6, 24, and 96 hours after left anterior descending coronary artery ligation (LAD CAL) in the dog.

Methods and Results—GRK activity was measured in arrhythmogenic subepicardial border zone (EBZ) tissue overlying the infarct and from nonischemic remote-site (RS) subepicardial tissue from the same animal. GRK activity in the ischemic EBZ was 15% of RS (P=0.03, n=6) 24 hours after CAL and appeared to start as early as 6 hours through 96 hours. GRK activity and immunoblot data demonstrated a marked decrease of GRK2 but not GRK5 at 24 hours. EBZ tissue exhibited high-affinity binding for (-)-isoproterenol (Ki of 0.076±0.026 nmol/L [SEM]) at 24 hours, which was not significantly different from control tissue from nonoperated animals (1.2±0.8 nmol/L, P>0.05, n=6). A significantly lower Ki of 13.8±2.8 nmol/L (P<0.001, n=6) was observed for RS taken from the ischemic animals. This was reflected by a 4-fold increase in the EC50 of isoproterenol-stimulated adenylyl cyclase activity from 18 nmol/L in EBZ tissue to 73 nmol/L in RS (P<0.05, n=4).

Conclusions—There is a selective decrease in GRK2 activity and a loss of the ability of the arrhythmia-prone EBZ tissue to desensitize to ß-adrenergic stimulation 24 hours after CAL. This correlates temporally with a second (late) peak in sudden cardiac death previously observed between 6 and 24 hours in dog and rat models of myocardial infarction.


Key Words: proteins • kinases • receptors, adrenergic, beta • death, sudden • myocardial infarction




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
X. Yu and D. C. Kem
Proteasome inhibition during myocardial infarction
Cardiovasc Res, October 4, 2009; (2009) cvp309v2.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Huang, E. Patterson, X. Yu, M. W. Garrett, I. De Aos, and D. C. Kem
Proteasome inhibition 1 h following ischemia protects GRK2 and prevents malignant ventricular tachyarrhythmias and SCD in a model of myocardial infarction
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1298 - H1303.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Yu, S. Huang, E. Patterson, M. W. Garrett, K. M. Kaufman, J. P. Metcalf, M. Zhu, S. T. Dunn, and D. C. Kem
Proteasome degradation of GRK2 during ischemia and ventricular tachyarrhythmias in a canine model of myocardial infarction
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1960 - H1967.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. Zaugg, M. C. Schaub, T. Pasch, and D. R. Spahn
Modulation of {beta}-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action
Br. J. Anaesth., January 1, 2002; 88(1): 101 - 123.
[Abstract] [Full Text] [PDF]